SCHEMBL6937141

SCHEMBL6937141

Nc1ccc(C2CC2)c(C2CC2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.61
CHRNA4 P43681 5/20 0.61
CYP3A4 P08684 2/20 0.39
CASP1 P29466 1/20 0.39
RECQL P46063 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
HTR1D P28221 1/20 0.38
HTR1B P28222 1/20 0.38
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TSHR P16473 1/20 0.33
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33
DAPK3 O43293 1/20 0.33
JAK2 O60674 1/20 0.33
PRKD3 O94806 1/20 0.33
MAP4K4 O95819 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23567637 1.00 CHRNB2 (0.61) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL2913382 0.93 CHRNB2 (0.55) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL451775 0.91 CHRNB2 (0.68) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL26291025 0.89 CHRNB2 (0.55) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL25989709 0.89 CHRNB2 (0.55) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL26309023 0.89 CHRNB2 (0.55) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL2061289 0.85 CHRNB2 (0.79) CHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL14394408 0.83 CHRNB2 (0.44) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL26755668 0.83 CHRNB2 (0.44) CHRNB2CHRNA4CYP3A4CASP1RECQL
SCHEMBL2916099 0.82 CHRNB2 (0.63) CHRNB2CHRNA4CYP3A4CASP1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021083182-A1 URICOSURIC AGENT, SYNTHETIC METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 南京明德新药研发有限公司 2021-05-06 WO disclosed
EP-1101756-B1 Aminopyrrolidine derivatives, processes for their preparation and pharmaceutical compositions comprising them SERVIER LAB (FR) 2003-03-19 EP disclosed
US-6300366-B1 FOR THERAPY OF CARDIOVASCULAR DISEASES, ESPECIALLY ARTERIAL HYPERTENSION, ARRHYTHMIA ADIR ET COMPAGNIE (FR) 2001-10-09 US disclosed
EP-1101756-A1 Aminopyrrolidine derivatives, processes for their preparation and pharmaceutical compositions comprising them ADIR ET COMPAGNIE (FR) 2001-05-23 EP disclosed